What Is CJC-1295 / Ipamorelin? A Medical Provider’s Guide to the Most Requested Growth Hormone Peptide Stack

Perfect B, Doral Fl. | 04.21.26 | 12 min read.

This content is for educational purposes only and does not constitute medical advice. Consult a qualified medical provider before beginning any peptide therapy protocol. All peptide medications referenced on this page require a clinical evaluation and prescription from a licensed provider. Results vary by patient.

What Is CJC-1295 Ipamorelin and Why It Is the Most Prescribed Peptide Stack at Our Clinic

If you have landed on this page searching what is CJC-1295 Ipamorelin, you are asking the right question. CJC-1295 Ipamorelin is a two-peptide combination that works together to stimulate your body’s own natural growth hormone release in a clean, selective way. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog, and Ipamorelin is a selective growth hormone secretagogue. Prescribed together as an injectable peptide stack, they are the most commonly requested protocol in our Doral, FL medical clinic and the most frequently searched growth hormone peptide in the United States. Volume on the primary search term has climbed from roughly 27,000 searches per month in late 2025 to over 60,000 per month in 2026, which tells you exactly how quickly this category is moving.

CJC-1295 Ipamorelin peptide therapy is not hormone replacement. It does not replace your growth hormone. It signals your pituitary gland to produce and release your own growth hormone in a pattern that more closely resembles what your body produced in your twenties. In practical terms that means deeper sleep, better recovery, improved body composition, and over months, meaningful shifts in lean muscle, fat distribution, skin quality, and overall steady-state energy.

Key Takeaways on What Is CJC-1295 Ipamorelin

• CJC-1295 Ipamorelin is a two-peptide stack combining a GHRH analog (CJC-1295) with a selective growth hormone secretagogue (Ipamorelin). They are prescribed together, not separately.
• The stack stimulates your own growth hormone, not replacing it. This is fundamentally different from hormone replacement and is why it has a cleaner side effect profile than direct HGH.
• The main reported benefits are deeper sleep, faster recovery, improved body composition (lean mass up, visceral fat down), better skin tone, and steady energy over 8 to 12 weeks.
• Ipamorelin is selective, meaning it triggers growth hormone without spiking cortisol or prolactin, which is why this stack is preferred over older peptides like GHRP-6.
• Every CJC-1295 Ipamorelin protocol at Perfect B in Miami begins with a licensed APRN intake, individualized dosing, and structured follow-up, not a one-size-fits-all prescription.

The Full Breakdown of CJC-1295 Ipamorelin Peptide Stack

To understand what is CJC-1295 Ipamorelin peptide therapy, you have to understand what each peptide does on its own. Then you see why the combination works the way it does.

CJC-1295: The GHRH Analog

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), the hormone your hypothalamus naturally secretes to tell your pituitary to release growth hormone. Native GHRH has a very short half-life in the body, only a few minutes. CJC-1295 is modified (the version used in our clinic is CJC-1295 without DAC) to extend that signal, keeping the GHRH stimulus present long enough for a meaningful pulse of growth hormone to occur.

Ipamorelin: The Selective Secretagogue

Ipamorelin peptide is a selective growth hormone secretagogue. It binds to the ghrelin receptor in the pituitary and triggers growth hormone release through a completely different pathway from CJC-1295. What makes Ipamorelin clinically attractive is its selectivity. Older secretagogues like GHRP-6 also stimulate hunger, cortisol, and prolactin. Ipamorelin does not. It triggers a clean GH pulse without the hormonal noise, a finding documented in a peer-reviewed European Journal of Endocrinology study demonstrating that Ipamorelin stimulates growth hormone selectively without elevating ACTH, cortisol, or prolactin. That selectivity is exactly why this particular secretagogue, stacked with CJC-1295, has become the default growth hormone peptide protocol in modern medical clinics.

Why Stacking Both Works Better Than Either Alone

CJC-1295 and Ipamorelin act on two different receptor pathways at the same pituitary cell. One amplifies the hypothalamic signal, the other triggers release through the ghrelin system. Together they produce a growth hormone pulse that is larger and more physiologically clean than either peptide alone. The CJC-1295 Ipamorelin benefits patients actually report (better sleep, improved body composition, steadier recovery) are downstream effects of that combined GH pulse, repeated nightly for weeks.

How the CJC-1295 Ipamorelin Peptide Stack Restores Your Natural GH Pulse

Growth hormone is not released in a steady stream. It is released in pulses, mostly at night during deep sleep, with the largest pulse typically occurring in the first 60 to 90 minutes after sleep onset. By your mid-thirties, those pulses have already started shrinking. By your forties and fifties, the amplitude is a fraction of what it was in your twenties. Patients do not usually complain about “low GH.” They complain about lighter sleep, longer recovery windows, a stubborn midsection, and softer skin. Those are the downstream signs of reduced GH pulse amplitude.

The CJC-1295 Ipamorelin stack is injected before bed, on an empty stomach, specifically to align with your natural overnight GH window. When you inject, CJC-1295 extends the GHRH signal and Ipamorelin triggers release through the ghrelin pathway, producing a GH pulse that more closely resembles what your pituitary produced in your twenties.

CJC-1295 Ipamorelin Benefits Our Miami Patients Actually Report

CJC-1295 Ipamorelin benefits tend to unfold in a predictable pattern across a 12-week cycle. What patients report in our Doral consultations looks remarkably consistent from one person to the next, with the exact timing varying based on age, baseline body composition, sleep habits, and training load.

• Week 1 to 2: Most patients notice the sleep change first. Falling asleep faster, sleeping more deeply, and waking more rested. This is the earliest and most universal sign the stack is working.
• Week 3 to 4: Recovery window shortens. Workouts that used to require two days of recovery start to turn over in one. Patients training regularly report this with unusual consistency.
• Week 4 to 8: Body composition begins to visibly shift. Lean muscle fills out, the midsection gets tighter, and patients who had plateaued in a weight-loss protocol often break through during this window.
• Week 8 to 12: Skin tone and texture improvements become visible. Hair and nail quality often improves in parallel. General steady-state energy feels more consistent across the day.
• Post-cycle: Benefits persist into the rest period when the protocol is built correctly with scheduled cycling on and off, which is the standard at our clinic.

The mechanism linking these effects is well-documented in the growth hormone literature. For a plain-language summary of growth hormone physiology and its role in body composition, sleep, and tissue repair, a peer-reviewed Nature Reviews Endocrinology paper examining the role of the growth hormone / IGF-1 axis in obesity, adult body composition, and metabolic regulation is a strong starting point.

Who Is a Good Candidate for CJC-1295 Ipamorelin Peptide Therapy

Not every patient who asks for CJC-1295 Ipamorelin is a candidate, and candid screening is part of what our intake is for. The patients who tend to get the most out of this stack share a common profile.

The Typical Good-Fit Patient

• Adults aged 30 to 65 who have noticed age-related shifts in sleep depth, body composition, and recovery that have not responded to diet, training, and sleep hygiene alone.
• Patients on GLP-1 medications (semaglutide, tirzepatide) who are losing weight but want to preserve lean muscle mass and improve body composition rather than just losing weight and shrinking.
• Active patients and athletes who need faster recovery between training sessions and want to optimize overnight repair windows.
• Post-surgical or post-injury patients in rebuilding phases where lean tissue preservation is important.
• Patients with chronic stubborn midsection adiposity that has been resistant to conventional weight-loss approaches.

Who Should Not Start This Stack

Because CJC-1295 Ipamorelin stimulates growth hormone, patients with active malignancy, a personal history of certain cancers, pregnancy, breastfeeding, uncontrolled diabetes, or significant pituitary disease are generally not candidates. Every CJC-1295 Ipamorelin protocol in our clinic starts with a contraindication review. If a patient is not a candidate, we say so directly rather than recommending a protocol that does not fit the case.

How CJC-1295 Ipamorelin Is Administered and Dosed

The CJC-1295 Ipamorelin cycle is straightforward in structure but requires precise execution to work. The delivery route is subcutaneous injection with a small insulin-size needle, typically into the abdomen or thigh, with daily site rotation.

Timing and Frequency

Injections are done once daily before bed, at least two hours after the last meal. The empty-stomach timing matters because ghrelin-pathway secretagogues like Ipamorelin are suppressed when insulin is elevated from a recent meal. The bedtime timing aligns the injected pulse with your natural overnight GH window. The standard cycle in our clinic is 5 days on and 2 days off per week, with the stack run in defined cycles followed by scheduled breaks between them.

Dose Titration

We start patients at a conservative dose and titrate upward over the first 8 to 12 weeks based on response and tolerance. Starting low and moving up is how you minimize the common early-week side effects (brief flushing, tingly hands, vivid dreams) while allowing the body to acclimate to the restored GH pulse. The exact dosing per patient is individualized during the intake, and the complete dosing structure, reconstitution guide, and cycle specifics are broken down in our dedicated CJC-1295 / Ipamorelin dosage and injection protocol guide at Perfect B covering reconstitution, timing, and titration.

CJC-1295 Ipamorelin Side Effects and Safety Profile

CJC-1295 Ipamorelin side effects are generally mild and most commonly appear in the first week or two of a cycle, then resolve as the body adapts. Because Ipamorelin is selective, this stack does not produce the classic GHRP-6 side effects (aggressive hunger, cortisol spike, prolactin elevation). What patients do report, typically transiently, includes:

• Injection site reaction: Brief redness or mild soreness where the needle entered, usually resolving within hours.
• Flushing: A warm, slightly red sensation across the face or chest for a few minutes after injection, most common in the first week.
• Tingling in the hands or feet: Occasional, usually brief, sometimes a sign dose is too high and needs titration.
• Vivid dreams: Common during the first 2 weeks and often a positive sign that sleep depth is increasing.
• Mild water retention: Occasional during the first weeks, typically resolving as the cycle progresses.
• Mild joint sensitivity: Uncommon, usually a sign the dose is elevated beyond what that patient needs.

Serious adverse events on this stack are rare when protocols are supervised and contraindications are respected. That is the core reason we insist on a licensed provider intake rather than a direct-to-consumer model. Anything that moves growth hormone should be run by someone tracking your response.

How CJC-1295 Ipamorelin Compares to Other Growth Hormone Peptides

Patients frequently ask how CJC-1295 Ipamorelin compares to Sermorelin, Tesamorelin, or direct HGH. The short answer is that each of these works on growth hormone but through different mechanisms, and the clinical use cases do not overlap perfectly.

• CJC-1295 Ipamorelin vs Sermorelin: Sermorelin is a simpler, older GHRH analog with a much shorter half-life and no secretagogue partner. The CJC-1295 Ipamorelin stack produces a larger, cleaner pulse in most patients.
• CJC-1295 Ipamorelin vs Tesamorelin: Tesamorelin is a GHRH analog specifically studied for visceral fat reduction. For body composition goals with a visceral fat focus, Tesamorelin is the more targeted peptide. For sleep, recovery, and lean mass, CJC-1295 Ipamorelin is the broader tool. We cover this directly in our full medical provider’s comparison of Tesamorelin vs CJC-1295 Ipamorelin for growth hormone goals, body composition, and visceral fat reduction.
• CJC-1295 Ipamorelin vs direct HGH: Direct human growth hormone (HGH) is a replacement drug. It overrides your pituitary and supplies exogenous GH. The peptide stack stimulates your own pulse pattern, which has a cleaner safety profile and does not shut down your endogenous production the way direct HGH can.
• CJC-1295 Ipamorelin vs Tesamorelin in practice: Our detailed write-up on Tesamorelin itself, including what it is and how it works, is in our full guide to the Tesamorelin peptide, what it is, how it works, and why searches are skyrocketing for patients weighing both options.

How CJC-1295 Ipamorelin Fits Into a Broader Peptide Treatment Plan

This stack is the central growth hormone protocol in our clinic, and it rarely runs in isolation. Depending on the patient’s goals, it is layered with recovery peptides, metabolic peptides, or a medically supervised weight-loss plan. Patients on GLP-1 weight-loss medications often run this stack alongside their GLP-1 to preserve lean muscle while dropping fat, which we detail in our medically supervised Weight Loss Treatment Plan at Perfect B in Miami that combines GLP-1 medications with supporting peptide protocols. Athletes often pair it with a BPC-157 and TB-500 recovery protocol during the repair phase. Patients focused on longevity sometimes layer in NAD+ and mitochondrial peptides for a more comprehensive approach.

How we select and sequence CJC-1295 Ipamorelin with these other protocols is detailed on our Peptide Treatment Plan page at Perfect B in Miami, covering every peptide we prescribe, how we stack them, and what outcomes we track.

→ If you are in the Miami area and thinking about growth hormone peptide therapy, book a consultation at Perfect B in Doral and get a protocol built specifically around your labs, goals, and body composition baseline.

Frequently Asked Questions

1. What is CJC-1295 Ipamorelin and why are both peptides used together?

CJC-1295 Ipamorelin is a two-peptide injectable stack. CJC-1295 is a GHRH analog that tells the pituitary to produce growth hormone through one pathway. Ipamorelin is a selective growth hormone secretagogue that triggers GH release through a different (ghrelin-receptor) pathway. Stacked together they produce a GH pulse that is larger and cleaner than either peptide alone, which is why this combination has become the standard growth hormone peptide protocol in modern medical clinics.

2. How long does it take to see results from CJC-1295 Ipamorelin?

Most patients notice a shift in sleep depth within the first one to two weeks. Recovery speed improvements typically show up in weeks three to four. Visible body composition changes (lean mass up, midsection tighter) usually become apparent between weeks four and eight. Skin tone, hair quality, and overall steady-state energy tend to settle in between weeks eight and twelve of a cycle.

3. What are the main CJC-1295 Ipamorelin benefits?

The main CJC-1295 Ipamorelin benefits patients report in our Miami practice are deeper sleep, faster recovery between workouts, improved lean muscle mass, reduced visceral fat, better skin tone, and steady-state energy across the day. These effects show up gradually over 8 to 12 weeks, not overnight, because they are downstream results of restoring a more youthful growth hormone pulse pattern.

4. What are the CJC-1295 Ipamorelin side effects?

The most common CJC-1295 Ipamorelin side effects are brief flushing after injection, mild injection site reaction, vivid dreams during the first two weeks, occasional tingling in the hands, and mild water retention early in the cycle. These are generally transient and resolve with dose titration or as the body adapts. Serious adverse events are rare when protocols are supervised and contraindications are respected.

5. Is CJC-1295 Ipamorelin the same as HGH?

No. CJC-1295 Ipamorelin is a growth hormone peptide stack that stimulates your own pituitary to release your own growth hormone. HGH (human growth hormone) is a replacement drug that supplies exogenous growth hormone directly. The peptide stack produces a physiologic pulse pattern that mimics natural release. Direct HGH overrides that pulse and can suppress your own endogenous production over time.

6. How is Ipamorelin different from CJC-1295?

Ipamorelin is a selective growth hormone secretagogue that binds to the ghrelin receptor. CJC-1295 is a GHRH analog that mimics the hypothalamic signal to the pituitary. They act on completely different receptor pathways to produce the same end result (growth hormone release). That is why they work better together than alone.

7. How much does CJC-1295 Ipamorelin cost at Perfect B in Miami?

At Perfect B, all peptides are priced equally per stack size and cycle count. A CJC-1295 Ipamorelin protocol is treated as a 2-peptide stack (two peptides in one protocol). Patients can run 1, 2, or 3 cycles, with the per-cycle cost decreasing at the higher cycle counts. Flexible financing through Cherry is available, split into up to 26 monthly payments, which lets most patients start their protocol the same day as the consultation.

Closing: The Clinical Bottom Line on What Is CJC-1295 Ipamorelin

CJC-1295 Ipamorelin peptide therapy is the most requested growth hormone protocol in our clinic for a reason. It restores a more youthful GH pulse pattern without replacing growth hormone directly, it has a cleaner side effect profile than older secretagogues, and the effects on sleep, recovery, body composition, and skin compound over 8 to 12 weeks in a predictable way. It is not a shortcut. It is a medically supervised protocol that works when it is paired with good sleep, training, and nutrition.

The difference between a CJC-1295 Ipamorelin cycle that delivers and one that does not is almost never the peptide itself. It is the intake, the dose titration, the cycle structure, the follow-up, and the quality of the compounded product. That is what supervised clinical care in a medical clinic provides and what an online research-peptide model cannot.

• 📍 Visit us at Perfect B, Doral FL, serving Miami and South Florida patients seeking supervised growth hormone peptide therapy.
• 📞 Call (786) 502-2260 or message us today to schedule your CJC-1295 Ipamorelin consultation with a licensed medical provider.

→ Book your personalized peptide consultation at Perfect B in Miami and get a CJC-1295 Ipamorelin protocol built around your specific goals, labs, and body composition baseline.